These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5800330)

  • 1. Drug withdrawal in male and female chronic schizophrenics.
    Abenson MH
    Br J Psychiatry; 1969 Aug; 115(525):961-2. PubMed ID: 5800330
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
    Platz AR; Klett CJ; Caffey EM
    Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216
    [No Abstract]   [Full Text] [Related]  

  • 3. Triiodothyronine and phenothiazines in schizophrenia.
    Wolpert A; Yaryura-Tobias JA; White L; Merlis S
    Dis Nerv Syst; 1969 Jul; 30(7):487-9. PubMed ID: 5810556
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical studies with propericiazine (R.P. 8909).
    St Jean A; Sterlin C; Noe W; Ban TA
    Dis Nerv Syst; 1967 Aug; 28(8):526-31. PubMed ID: 4383004
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum vitamin-B12 levels in psychiatric patients on long-term psychotropic drug therapy.
    Henderson JG; Dawson AA
    Br J Psychiatry; 1970 Apr; 116(533):439-42. PubMed ID: 5441804
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical effects of various schedules of medication.
    Chien CP; DiMascio A
    Behav Neuropsychiatry; 1971; 3(1):5-9. PubMed ID: 5566336
    [No Abstract]   [Full Text] [Related]  

  • 7. Intermittent pharmacotherapy in chronic schizophrenia.
    Prien RF; Gillis RD; Caffey EM
    Hosp Community Psychiatry; 1973 May; 24(5):317-22. PubMed ID: 4574574
    [No Abstract]   [Full Text] [Related]  

  • 8. Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy.
    Logothetis J
    Neurology; 1967 Sep; 17(9):869-77. PubMed ID: 6069087
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients.
    Spiegel DE; Keith-Spiegel P
    J Nerv Ment Dis; 1967 Feb; 144(2):111-6. PubMed ID: 5338760
    [No Abstract]   [Full Text] [Related]  

  • 10. High dose trifluoperazine therapy in chronic schizophrenia.
    Prien RF; Levine J; Cole JO
    Am J Psychiatry; 1969 Sep; 126(3):305-13. PubMed ID: 4895559
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of dosage ranges of carphenazine and trifluoperazine in elderly chronic schizophrenics.
    Bora G
    Dis Nerv Syst; 1968 Oct; 29(10):695-7. PubMed ID: 4887393
    [No Abstract]   [Full Text] [Related]  

  • 12. High doses of trifluperazine and tardive dyskinesia.
    Crane GE
    Arch Neurol; 1970 Feb; 22(2):176-80. PubMed ID: 4902773
    [No Abstract]   [Full Text] [Related]  

  • 13. Are antipsychotic drugs interchangeable?
    Gardos G
    J Nerv Ment Dis; 1974 Nov; 159(5):343-8. PubMed ID: 4612111
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of thioridazine tablets to chlorpromazine spansules in the maintenance care of chronic schizophrenics.
    Bartlett C
    Curr Ther Res Clin Exp; 1971 Feb; 13(2):100-6. PubMed ID: 4994211
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting response to phenothiazines: the right drug for the right patient.
    Galbrecht CR; Klett CJ
    J Nerv Ment Dis; 1968 Aug; 147(2):173-83. PubMed ID: 5677325
    [No Abstract]   [Full Text] [Related]  

  • 16. [WITHDRAWAL OF PSYCHOPHARMACA AND RELAPSE IN SCHIZOPHRENICS].
    PETERSEN PB
    Ugeskr Laeger; 1964 Oct; 126():1388-93. PubMed ID: 14239325
    [No Abstract]   [Full Text] [Related]  

  • 17. Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time.
    Goldberg SC; Schooler NR; Mattsson N
    J Nerv Ment Dis; 1967 Aug; 145(2):158-62. PubMed ID: 4861752
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug therapy of thought disorder in chronic paranoid schizophrenia: a longitudinal study.
    Wilson IC; Paulson GW; Sandifer MG
    Dis Nerv Syst; 1968 Aug; 29(8):550-1. PubMed ID: 4877898
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of dosage in antipsychotic drug administration--a review of dose-response studies.
    Gardos G; Cole JO
    Psychopharmacologia; 1973; 29(3):221-30. PubMed ID: 4144989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.